About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Human Metabolome Technologies, Inc.(6090) Summary

6090
TSE Growth
Human Metabolome Technologies, Inc.
709
JPY
+2
(+0.28%)
May 1, 10:58 am JST
4.95
USD
Apr 30, 9:58 pm EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
14.7
PBR
2.18
Yield
2.12%
Margin Trading Ratio
Stock Price
May 1, 2025
Opening May 1, 10:27 am
702 JPY 4.90 USD
Previous Close Apr 30
707 JPY 4.95 USD
High May 1, 10:58 am
709 JPY 4.95 USD
Low May 1, 10:30 am
697 JPY 4.87 USD
Volume
1,500
Trading Value
1.00M JPY 7.41K USD
VWAP
703.47 JPY 4.94 USD
Minimum Trading Value
70,900 JPY 495 USD
Market Cap
4.20B JPY 0.03B USD
Number of Trades
6
Liquidity & Number of Trades
As of May 1, 2025
Liquidity
Slightly Low
1-Year Average
26
1-Year High Aug 6, 2024
131
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 25, 2025 0 209,900
Apr 18, 2025 0 206,400
Apr 11, 2025 0 210,100
Apr 4, 2025 0 211,700
Mar 28, 2025 0 214,900
Company Profile
Human Metabolome Technologies, Inc. is a biotech venture company originating from Keio University. The company specializes in metabolite analysis services and biomarker detection.
Sector
Services
Human Metabolome Technologies develops businesses utilizing metabolome analysis and biotechnology. Through its comprehensive metabolite analysis technology using CE-MS method, the company engages in two main business areas: advanced research and development support, and healthcare solutions. In the former, the company provides metabolome analysis services to food, chemical, and pharmaceutical companies, as well as research institutions. In the latter, it supports the development of functional materials.